{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:18:11Z","timestamp":1782703091351,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1124\/jpet.115.230193","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T04:39:01Z","timestamp":1456288741000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Repeated Dosing with NCX1404, a Nitric Oxide\u2013Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy"],"prefix":"10.1016","volume":"357","author":[{"given":"Katia","family":"Varani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Targa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bastia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Storoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Impagnatiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.230193_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2006.12.003","article-title":"Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study","volume":"77","author":"Agrawal","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/jpet.115.230193_bib2","first-page":"205","article-title":"Ultrastructural investigations on protective effects of NCX 4016 (nitroaspirin) on macrovascular endothelium in diabetic Wistar rats","volume":"37","author":"Ambrosini","year":"2005","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1124\/jpet.115.230193_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-6147(00)01499-1","article-title":"The dual personality of NO","volume":"21","author":"Colasanti","year":"2000","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 3","key":"10.1124\/jpet.115.230193_bib4","first-page":"S54","article-title":"Endothelial dysfunction in diabetes mellitus","volume":"32","author":"Cosentino","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.104.067934","article-title":"XP13512 [(+\/\u2212)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters","volume":"311","author":"Cundy","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.230193_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.2009.00343.x","article-title":"Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin","volume":"158","author":"Curros-Criado","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.115.230193_bib8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7547\/87507315-67-12-874","article-title":"Nitroglycerin ointment as a vasodilator in the lower extremities","volume":"67","author":"Francis","year":"1977","journal-title":"J Am Podiatry Assoc"},{"key":"10.1124\/jpet.115.230193_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.105.097469","article-title":"In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate","volume":"317","author":"Govoni","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.230193_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/1440-1681.12442","article-title":"The furoxan nitric oxide donor, PRG150, evokes dose-dependent analgesia in a rat model of painful diabetic neuropathy","volume":"42","author":"Huang","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.115.230193_bib11","first-page":"1163","article-title":"A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain","volume":"11","author":"King","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/jpet.115.230193_bib12","first-page":"11","article-title":"Bioactivation of organic nitrates and the mechanism of nitrate tolerance","volume":"16","author":"Klemenska","year":"2009","journal-title":"Cardiol J"},{"key":"10.1124\/jpet.115.230193_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0022-3565(24)39019-6","article-title":"ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat","volume":"295","author":"Kowaluk","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.230193_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1399-6576.2009.02054.x","article-title":"Nitric oxide and pain: \u2018Something old, something new\u2019","volume":"53","author":"Miclescu","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/jpet.115.230193_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2009.01.048","article-title":"Modulation of P2X receptors in dorsal root ganglion neurons of streptozotocin-induced diabetic neuropathy","volume":"452","author":"Migita","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.115.230193_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/jpet.103.057877","article-title":"Continuous administration of organic nitrate decreases hepatic cytochrome P450","volume":"308","author":"Minamiyama","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.230193_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2005.12.006","article-title":"The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin","volume":"531","author":"Mixcoatl-Zecuatl","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10787-015-0240-5","article-title":"Involvement of NO-cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia","volume":"23","author":"Otari","year":"2015","journal-title":"Inflammopharmacology"},{"key":"10.1124\/jpet.115.230193_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.115.230193_bib20","first-page":"H825","article-title":"Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta","volume":"255","author":"Pieper","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.115.230193_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9136(199704)14:4<284::AID-DIA348>3.0.CO;2-0","article-title":"NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy","volume":"14","author":"Pitei","year":"1997","journal-title":"Diabet Med"},{"key":"10.1124\/jpet.115.230193_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/JPR.S21751","article-title":"High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy","volume":"4","author":"Purwata","year":"2011","journal-title":"J Pain Res"},{"key":"10.1124\/jpet.115.230193_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(00)02235-6","article-title":"Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats","volume":"865","author":"Rodella","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/jpet.115.230193_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1476-5381.2009.00324.x","article-title":"NCX 2057, a novel NO-releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in in vitro and in vivo models","volume":"158","author":"Ronchetti","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2005.12.034","article-title":"Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages","volume":"532","author":"Ronchetti","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00001756-199801260-00013","article-title":"Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats","volume":"9","author":"Sasaki","year":"1998","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.115.230193_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0076-6879(91)06102-9","article-title":"Induction of diabetes and evaluation of diabetic state on P450 expression","volume":"206","author":"Schenkman","year":"1991","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.115.230193_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tins.2009.01.010","article-title":"No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing","volume":"32","author":"Schmidtko","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.115.230193_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: Physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1124\/jpet.115.230193_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2004.07.085","article-title":"Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia","volume":"498","author":"Szolcs\u00e1nyi","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bjp.0706731","article-title":"Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury","volume":"148","author":"Takasu","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuropharm.2014.01.028","article-title":"TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice","volume":"81","author":"Vincenzi","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.230193_bib34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/bmj.288.6412.168","article-title":"Pain and diabetic neuropathy","volume":"288","author":"Watkins","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1124\/jpet.115.230193_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1529-8027.2007.00144.x","article-title":"Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db\/db) mice","volume":"12","author":"Wright","year":"2007","journal-title":"J Peripher Nerv Syst"},{"key":"10.1124\/jpet.115.230193_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjp.0705596","article-title":"A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury","volume":"141","author":"Wu","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.230193_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1071576031000083161","article-title":"The role of oxidative stress in diabetic vascular and neural disease","volume":"37","author":"Yorek","year":"2003","journal-title":"Free Radic Res"},{"key":"10.1124\/jpet.115.230193_bib38","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/diacare.25.10.1699","article-title":"Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study","volume":"25","author":"Yuen","year":"2002","journal-title":"Diabetes Care"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524192944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524192944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.230193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:44:15Z","timestamp":1739994255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524192944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0022356524192944"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.230193","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated Dosing with NCX1404, a Nitric Oxide\u2013Donating Pregabalin, Re-establishes Normal Nociceptive Responses in Mice with Streptozotocin-Induced Painful Diabetic Neuropathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.230193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}